Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Illumina, Inc.    ILMN

ILLUMINA, INC.

(ILMN)
  Report
Delayed Quote. Delayed Nasdaq - 10/23 04:00:00 pm
323.55 USD   -0.73%
10/07ILLUMINA, INC. : Report
CO
10/05ILLUMINA, INC. : Report
CO
10/01ILLUMINA, INC. : Report
CO
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Illumina : Correction to Illumina Acquisition of Grail Article

share with twitter share with LinkedIn share with facebook
09/21/2020 | 08:46am EDT

Francis deSouza is chief executive of Illumina Inc. "Sequencing Firm Illumina to Pay $7.1 Billion for Liquid-Biopsy Firm Grail -- Update" at 7:53 a.m. ET incorrectly said Mr. deSouza was CEO of Grail. (Sept. 21, 2020)

 


share with twitter share with LinkedIn share with facebook
All news about ILLUMINA, INC.
10/07ILLUMINA, INC. : Report
CO
10/05ILLUMINA, INC. : Report
CO
10/01ILLUMINA, INC. : Report
CO
09/28ILLUMINA : to Announce Third Quarter 2020 Financial Results on Thursday, October..
BU
09/25JOHNSON & JOHNSON, NIKE, ILLUMINA : Stocks That Defined the Week
DJ
09/23ILLUMINA : to Webcast Upcoming Investor Conference Presentation
BU
09/21Nikola, Illumina fall; Cubic, Rent-A-Center rise
AQ
09/21Nikola, Illumina fall; Cubic, Rent-A-Center rise
AQ
09/21Illumina to buy Jeff Bezos-backed cancer testing firm Grail in £6.23 billion ..
RE
09/21JEFF BEZOS : Illumina to buy Jeff Bezos-backed cancer testing firm Grail in $8 b..
RE
More news
Financials (USD)
Sales 2020 3 095 M - -
Net income 2020 550 M - -
Net cash 2020 2 068 M - -
P/E ratio 2020 87,9x
Yield 2020 -
Capitalization 47 355 M 47 355 M -
EV / Sales 2020 14,6x
EV / Sales 2021 11,8x
Nbr of Employees 7 700
Free-Float 75,1%
Chart ILLUMINA, INC.
Duration : Period :
Illumina, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ILLUMINA, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Average target price 297,25 $
Last Close Price 323,55 $
Spread / Highest target 17,4%
Spread / Average Target -8,13%
Spread / Lowest Target -32,0%
EPS Revisions
Managers
NameTitle
Francis A. deSouza President, Chief Executive Officer & Director
Jay T. Flatley Executive Chairman
Robert P. Ragusa Senior Vice President-Global Quality & Operations
Sam A. Samad Chief Financial Officer & Senior Vice President
Phillip G. Febbo Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ILLUMINA, INC.-2.47%47 355
THERMO FISHER SCIENTIFIC47.80%189 950
DANAHER CORPORATION51.59%165 276
INTUITIVE SURGICAL, INC.24.42%86 460
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.95.16%64 541
BOSTON SCIENTIFIC CORPORATION-17.80%53 178